Replimune Group Inc
REPL
NASDAQ
Biotechnology
$14.97
USD
-0.22 (-1.45%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $1.28B
Volume 2.4M
Peer Comparison Table
(1/4) | ||||||
|---|---|---|---|---|---|---|
REPL | Replimune Group Inc | $1.28B | - | - | - | |
CGEM | Cullinan Therapeutics Inc | $1.18B | - | - | - | |
ODTX | Odyssey Therapeutics Inc | $1.07B | - | -19.0% | - | |
AVTX | Avalo Therapeutics Inc | $1.04B | - | -86.6% | - | |
OLMA | Olema Pharmaceuticals Inc | $1.04B | - | - | - | |
GERN | Geron Corp | $1.01B | - | +24.4% | - | |
SANA | Sana Biotechnology Inc | $1.00B | - | - | - | |
JANX | Janux Therapeutics Inc | $1.00B | - | +5367.0% | - | |
ARDX | Ardelyx Inc | $989.27M | - | +16.8% | - |
Top Peer by Growth
Inhibrx Biosciences Inc
+550.0% YoY Revenue
Best 1-Year Return
Inhibrx Biosciences Inc
+348.7% Return